Study of a new injection for advanced solid tumors
Part of Cancer clinical trials.
This study tests an experimental drug called SHR-4595 given as a shot (injection) to people with advanced solid tumors. The goal is to see if it is safe and how the body handles it, which might help shrink tumors or slow their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of advanced solid tumor cancer that has not responded to standard treatments, or for which no standard treatment exists, or you have chosen not to have standard treatment.
- At least one tumor must be measurable on a scan (like CT or MRI).
- You should be able to take care of yourself and be up and about (ECOG status 0 or 1).
- You need to have a life expectancy of at least 12 weeks (about 3 months).
- You cannot have untreated or active brain metastases, serious heart problems, active autoimmune diseases, or active hepatitis B or C infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called SHR-9839 given under the skin, combined with other anti-cancer treatments, for people with solid tumors. The goal is to see if it is safe and effective.
This trial tests a new drug, SHR-4685, for people with solid tumors that are measurable. It aims to see if the drug is safe and how your body processes it.
This study tests an experimental drug called SHR-A1811 given as a shot under the skin (subcutaneous injection) for people with solid tumors. It aims to see if the drug is safe and how well it works.
This trial tests a new drug, SHR-4506, for people with advanced cancers that have stopped responding to standard treatments or cannot be treated with standard options. It aims to see if the drug is safe and helpful.
This study tests a new experimental drug, SHR-4375, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective for these cancers.
This trial tests a new drug called SHR-3792 for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if the drug is safe and how it affects the tumors.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.